ArticleMedical science monitor : international medical journal of experimental and clinical research2014

Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.

Ying-Li Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.